A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

Clinical trial NCT04569838 · COMPLETED

Trial details

NCT number: NCT04569838
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent B-Cell Non-Hodgkin's Lymphomas

Start date: 2012-05-01
Primary completion: 2016-08-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.